Numerous NHS organizations in England are opting not to use Palantir's patient data platform, citing the availability of better or equivalent alternatives. While some trusts reported improvements in managing waiting lists and surgery scheduling, many have reverted to previous systems after trials, questioning the platform's effectiveness.
The ongoing debate over Palantir's role in the NHS coincides with a government decision regarding the continuation of its contract. Concerns about data privacy and the company's controversial background have fueled opposition, leading to calls for a reevaluation of the partnership.
With multiple NHS trusts opting out of Palantir's platform, watch for potential shifts in government strategy regarding data management in healthcare. Stakeholders may push for more localized solutions, emphasizing the need for interoperability and trust in data handling.